Shares of Novavax fell more than 20% on Wednesday after the vaccine maker reported fourth-quarter revenue and earnings that missed Wall Street’s estimates and said it expects full-year 2024 sales to … [+5109 chars]Read More
Novavax stock falls 20 as vaccine maker misses quarterly estimates sees sluggish 2024 sales CNBC
